<DOC>
	<DOCNO>NCT00171756</DOCNO>
	<brief_summary>A study compare effect Diovan Atenolol take 12 week platelet function patient mild moderately severe hypertension</brief_summary>
	<brief_title>Study Compare Effect Valsartan v Atenolol Pro-thrombotic State Hypertensive Patients .</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Atenolol</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<criteria>Male female , age 18 75 year age inclusively . Mild moderate hypertension ( MSDBP &gt; = 95 &gt; = 110 mmHg / MSSBP &gt; 140mm Hg ) visit 1 , require pharmacological intervention . For newly diagnose patient , hypertensive blood pressure value must note least two successive examination prior entry study . In addition , patient must require therapy despite follow dietary &amp; lifestyle advice least 3 month . Written inform consent participate study , prior study procedure . Ability communicate comply study requirement Uncontrolled hypertension define seat blood pressure either systolic BP &gt; 180 mmHg and/or diastolic BP &gt; 110mmHg . Clinically significant laboratory abnormality may interfere assessment safety and/or efficacy study drug Patients severe medical condition ( ) view investigator may prohibit participation study Renal artery stenosis Diabetes Mellitus Any condition result leading platelet clot abnormality ( eg . hemophilia , von Willebrand 's disease ) . History vascular event intervention ( e.g . MI , PTCA CABG ) within 6 month precede study . History clinically significant angina , LVH , transient ischemic attack , stroke , intermittent claudication , deep vein thrombosis ( DVT ) , pulmonary embolism peripheral vascular disease . Uncontrolled atrial fibrillation ( &gt; 100 b.p.m . rest ) condition may require antiaggregant antivitamin K therapy . Clinical evidence congestive heart failure . Evidence second third degree heart block sick sinus syndrome .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>hypertension</keyword>
	<keyword>valsartan</keyword>
</DOC>